Literature DB >> 1081925

Cell-mediated immunity in rubella assayed by cytotoxicity of supernatants from rubella virus-stimulated human lymphocyte cultures.

T Vesikari, G Y Kanra, E Buimovici-Klein, L Z Cooper.   

Abstract

Rubella virus-stimulated lymphocytes from rubella-seropositive donors produced in the culture medium cytotoxic activity with preferential action against rubella-infected over uninfected target cells. The ability of lymphocytes to produce the cytotoxic activity upon stimulation by rubella virus correlated with the humoral rubella-immunity status, i.e. no such cytotoxic activity developed in the supernatants of lymphocyte cultures of rubella-seronegative donors. Stimulation of lymphocytes from seropositive donors by rubella virus was also detected by thymidine incorporation, but the correlation of lymphocyte responsiveness to the humoral rubella antibody status was not so clear as in the cytotoxicity assay. Conversion of lymphocytes from unresponsive to responsive to rubella virus following natural rubella infection and after rubella vaccination was demonstrated using both methods. Following vaccination rubella-specific cell-mediated immunity first became demonstrable at 14 days. The responsiveness of lymphocytes to phytohaemagglutinin (PHA) after rubella vaccination was followed by studying thymidine uptake and the ability of lymphocytes to produce lymphootoxin. By both tests marked suppression of PHA response occurred at days 3 and 7 after vaccination.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1081925      PMCID: PMC1538021     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  15 in total

1.  DEPRESSION OF THE TUBERCULIN REACTION BY VIRAL VACCINES.

Authors:  J A BRODY; T OVERFIELD; L M HAMMES
Journal:  N Engl J Med       Date:  1964-12-17       Impact factor: 91.245

2.  An immuno-cytopathogenic interaction between sensitized leukocytes and epithelial cells carrying a persistent noncytocidal myxovirus infection.

Authors:  L F Speel; J E Osborn; D L Walker
Journal:  J Immunol       Date:  1968-09       Impact factor: 5.422

3.  Rubella virus and human lymphocytes in culture.

Authors:  M J Simons; M G Fitzgerald
Journal:  Lancet       Date:  1968-11-02       Impact factor: 79.321

4.  Lymphoblast proliferation and humoral antibody response after rubella vaccination.

Authors:  M Lalla; T Vesikari; M Virolainen
Journal:  Clin Exp Immunol       Date:  1973-10       Impact factor: 4.330

5.  Some effects of rubella vaccination of immunologic responsiveness.

Authors:  M Midulla; L Businco; L Moschini
Journal:  Acta Paediatr Scand       Date:  1972-09

6.  Induction of delayed hypersensitivity to influenza and mumps viruses in mice.

Authors:  S M Feinstone; E H Beachey; M W Rytel
Journal:  J Immunol       Date:  1969-10       Impact factor: 5.422

7.  The relationship between rubella hemagglutination inhibition antibody (HIA) and rubella induced in vitro lymphocyte tritiated thymidine incorporation.

Authors:  K A Smith; L Chess; M R Mardiney
Journal:  Cell Immunol       Date:  1973-08       Impact factor: 4.868

8.  The lymphocyte response to primary Moloney sarcoma virus tumors in BALB-c mice. Definition of the active subpopulations at different times after infection.

Authors:  E W Lamon; H Wigzel; E Klein; B Andersson; H M Skurzak
Journal:  J Exp Med       Date:  1973-06-01       Impact factor: 14.307

9.  In vitro stimulation of sensitized lymphocytes by herpes simplex virus and vaccinia virus.

Authors:  G L Rosenberg; P A Farber; A L Notkins
Journal:  Proc Natl Acad Sci U S A       Date:  1972-03       Impact factor: 11.205

10.  Synergistic or antgonistic effect of different antibody concentrations on in vitro lymphocyte cytotoxicity in the Moloney sarcoma virus system.

Authors:  H M Skurzak; E Klein; T O Yoshida; E W Lamon
Journal:  J Exp Med       Date:  1972-04-01       Impact factor: 14.307

View more
  5 in total

1.  Lymphocyte responses to rubella antigen and phytohemagglutinin after administration of the RA 27/3 strain of live attenuated rubella vaccine.

Authors:  T Vesikari; E Buimovici-Klein
Journal:  Infect Immun       Date:  1975-04       Impact factor: 3.441

Review 2.  T Lymphocytes as Measurable Targets of Protection and Vaccination Against Viral Disorders.

Authors:  Anne Monette; Andrew J Mouland
Journal:  Int Rev Cell Mol Biol       Date:  2018-10-24       Impact factor: 6.813

3.  Cytotoxic activity against rubella-infected cells in the supernatants of human lymphocyte cultures stimulated by rubella virus.

Authors:  G Y Kanra; T Vesikari
Journal:  Clin Exp Immunol       Date:  1975-01       Impact factor: 4.330

4.  Correlation between rubella antibody levels and cytokine measures of cell-mediated immunity.

Authors:  Pritish K Tosh; Richard B Kennedy; Robert A Vierkant; Robert M Jacobson; Gregory A Poland
Journal:  Viral Immunol       Date:  2009-12       Impact factor: 2.257

5.  Lymphocyte transformation induced by autologous cells. VIII. Impaired autologous mixed lymphocyte reactivity in patients with acute infectious mononucleosis.

Authors:  C E Moody; B A Casazza; W N Christenson; M E Weksler
Journal:  J Exp Med       Date:  1979-12-01       Impact factor: 14.307

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.